Delphinus Medical Technologies, Inc.
Mark J Forchette has a strong work history, starting with their most recent role as Director at Auburn University Foundation since January 2020. Prior to that, they served as President & CEO of Delphinus Medical Technologies, Inc. from September 2014. Before that, they held the position of President & CEO at Optimedica from June 2007 to February 2014. Mark also worked at Alcon Laboratories as Vice President / Vit Sales & Global Mktg from May 1998 to May 2007, and at Grieshaber & Company as Vice President / Sales from August 1984 to May 1998. Mark J served as Vice President of Sales at Donnelly Communications, Inc. from May 1983 to August 1984, and as a Field Sales Representative at The Dial Corporation from December 1981 to May 1983.
Mark J Forchette completed their Bachelor of Science (BS) in Marketing from Auburn University, attending from 1978 to 1981. Mark J also briefly enrolled in the Executive Education program at Harvard Business School in 2003, focusing on Business.
This person is not in any offices
Delphinus Medical Technologies, Inc.
Delphinus Medical Technologies develops, commercializes, sells, and services the breast cancer screening solutions to hospitals and imaging clinics in the United States and internationally. It commercializes SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women's breasts for the presenceof benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. The company was founded in 2009 and is based in Detroit, Michigan.